推动早期肺癌领域的发展
推动早期肺癌领域的发展 ADAURA:辅助化疗的作用 约30%的非小细胞肺癌(NSCLC
推动早期肺癌领域的发展 ADAURA:辅助化疗的作用 约30%的非小细胞肺癌(NSCLC
序言 Ross A. Soo, MB BS, PhD, FRACP 新加坡国立大学癌
J-AXEL: nab-paclitaxel at least equal to docetax
Nivolumab as a new option in patients with relap
Interview: Lung cancer screening: hurdles in daily rou
Immunotherapy: combination regimens and new data
What is new in SCLC? Lurbinectedin plus irin
Interview: Antibody-drug conjugates: the age of
Specific treatment approaches in the EGFR-mutate
KRAS, HER2 & ALK: targeted options and seque